Our mission: Save lives through improved patient care.
At NeoGenomics, everything we do is to better patient care. We are dedicated to increasing and improving access to care and advancing patient outcomes through transformative oncology testing. As a leader in cancer diagnostics, NeoGenomics has more than 15 years of experience diagnosing and analyzing various forms of solid tumors and blood cancers. Our organization is an integral part of the cancer care team by providing vital insights about a cancer’s diagnosis, prognosis, and therapy assignment. We work with oncology providers to give insights into your cancer’s thumbprint and help guide personalized treatment decisions to help optimize care, also known as precision medicine.
NeoGenomics takes cancer personally; every person is unique and we believe in walking hand-in-hand with you and your care team during your personal cancer journey.
Testing Methods and Tumor Profiling
NeoGenomics performs cancer testing using every available methodology. Your doctor may request one or more methods to help diagnose and determine a treatment plan that is appropriate for you.
NeoGenomics offers in-home blood draws for our lung cancer (InVisionFirst® –Lung), Pan-Cancer (NeoLAB® Solid Tumor Liquid Biopsy) and hematologic cancers (NeoLAB® Heme Liquid Biopsy). These in-home blood draw tests are no charge to patients.
NeoGenomics works with partners and providers to create pathways to emerging advances in personalized medicine. These programs offer access to new and emerging advances to personalized medicine at reduced or no-cost tests to patients.